Charles D. Goodwin II - 14 Nov 2023 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role: Chief Executive Officer, Director
Signature: /s/ Charles D. Goodwin, II
Issuer symbol: APYX
Transactions as of: 14 Nov 2023
Net transactions value: +$78,500
Form type: 4
Filing time: 15 Nov 2023, 16:12:42 UTC
Previous filing: 13 Jan 2023
Next filing: 11 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APYX	Common Stock	Purchase	$78,500	+50,000	+125%	$1.57	90,000	14 Nov 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at a prices ranging from $1.56 to $1.57. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Content

This transaction was executed in multiple trades at a prices ranging from $1.56 to $1.57. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.